Status:
COMPLETED
Effect of Heart-lung-machine on Selenium Status of Cardiac Surgical Patients Undergoing Coronary Bypass Surgery
Lead Sponsor:
RWTH Aachen University
Conditions:
Selenium Level
Eligibility:
All Genders
18+ years
Brief Summary
Since selenium has demonstrated significant characteristics for a series of biochemical processes, for antioxidant activity and immune stimulation, this observational study should represent the effect...
Detailed Description
To produce two comparable groups of patients, the characteristics are recorded using EURO-Score; additionally the groups are "matched" (Matched-Pairs-Analysis). All patients are operated by the same ...
Eligibility Criteria
Inclusion
- Coronary-3-vessel-disease
- Written informed consent
- Age of 18 years or older
- Study inclusion at the latest on the last evening before surgery
Exclusion
- Other serious cardiac diagnosis (i.e. aneurysm, valvular-diseases)
- ischemic cardiomyopathy
- Patients not capable of consenting
- Pregnant or lactating women, women of child-bearing potential in whom pregnancy can not be excluded
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01409057
Start Date
June 1 2010
End Date
December 1 2012
Last Update
December 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Aachen
Aachen, Germany, 52074